Description
Recently, the biotech world has faced more venture funds coming from emerging markets than ever before. Together, Russia, China and India have all invested in global success stories with well-known venture funds. Attendees will hear from experts as they ask the questions: What does this VC model look like? The funds might have big ambitions, high-level expertise and access to new lower-competition markets however should one cooperate with them and if so, how?

Session ID: 21929

Educational Topics